PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 • Medical devices companies - Market size and forecast 2018-2023 • Food and beverage manufacturers - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Charles River • GenScript • Lonza • Merck KGaA • Thermo Fisher Scientific Inc. PART 13: APPENDIX • Research methodology • List of abbreviations   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%) Exhibit 21: Medical devices companies - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Medical devices companies - Year-over-year growth 2019-2023 (%) Exhibit 23: Food and beverage manufacturers - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Food and beverage manufacturers - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Advantages of using software with pyrogen testing systems Exhibit 40: Impact of drivers and challenges Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Charles River - Vendor overview Exhibit 47: Charles River - Product segments Exhibit 48: Charles River - Organizational developments Exhibit 49: Charles River - Geographic focus Exhibit 50: Charles River - Segment focus Exhibit 51: Charles River - Key offerings Exhibit 52: GenScript - Vendor overview Exhibit 53: GenScript - Business segments Exhibit 54: GenScript - Organizational developments Exhibit 55: GenScript - Geographic focus Exhibit 56: GenScript - Segment focus Exhibit 57: GenScript - Key offerings Exhibit 58: Lonza - Vendor overview Exhibit 59: Lonza - Business segments Exhibit 60: Lonza - Organizational developments Exhibit 61: Lonza - Geographic focus Exhibit 62: Lonza - Segment focus Exhibit 63: Lonza - Key offerings Exhibit 64: Merck KGaA - Vendor overview Exhibit 65: Merck KGaA - Business segments Exhibit 66: Merck KGaA - Organizational developments Exhibit 67: Merck KGaA - Geographic focus Exhibit 68: Merck KGaA - Segment focus Exhibit 69: Merck KGaA - Key offerings Exhibit 70: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 71: Thermo Fisher Scientific Inc. - Business segments Exhibit 72: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 73: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 74: Thermo Fisher Scientific Inc. - Segment focus Exhibit 75: Thermo Fisher Scientific Inc. - Key offerings Exhibit 76: Validation techniques employed for market sizing

Charles River GenScript Lonza Merck KGaA and Thermo Fisher Scientific Inc